Alta Semper Capital

What Alta Semper Capital does

Alta Semper Capital LLP is a London-headquartered private equity firm founded in 2015 by Afsane Jetha, Richard D. Parsons (former CEO of Time Warner), and members of the Estée Lauder family, including Ronald Lauder. The firm invests flexible capital — typically US$20-60 million per transaction — into controlling or active minority stakes in healthcare, health-tech, and consumer companies across 12 large African economies (Egypt, Kenya, Morocco, Nigeria, Ghana, Tanzania, Ethiopia, Uganda, Mozambique, Tunisia, and others), supplemented by selective MENA exposure. The firm operates through regional offices in Cairo, Nairobi, Lagos, and Port Louis, supported by on-the-ground operating partners in North, East, and West Africa.

The portfolio consists of five majority-owned platforms spanning medical devices (Allmed Group — UK/Egypt-based blood purification and dialysis manufacturer exporting to 40+ countries, including its proprietary NIDUS Infant Haemodialysis System), digital health and e-pharmacy (MyDawa — the largest e-pharmacy in East Africa with telemedicine and emerging AI features), oncology and diagnostics services (ODM in Morocco, expanding into Senegal, Ivory Coast, and Tunisia), cosmeceuticals (Macro Pharmaceuticals in Egypt), and sports nutrition (Nature's Rule in the UAE with Egyptian manufacturing). The firm layers a technology overlay strategy — digital health, low-cost mobile medical equipment, last-mile software, supply chain, and enabling financial services — onto its healthcare and consumer theses.

Alta Semper's revenue is generated through management fees and carried interest on private equity funds managed on behalf of founding shareholders and US/European institutional investors. The first fund was anchored by IFC, and Growth Fund II secured US$57.5 million in commitments in January 2026 from EIB Group (US$37.5 million) and IFC (US$20 million), targeting a total fund size of US$150 million. The firm is recognized as an EPiHC signatory and is fully IFC-compliant on environmental and social performance standards, and received the Development Impact Award at the Private Equity Africa Annual Awards 2022.

Name

Alta Semper Capital

Legal name

Alta Semper Capital LLP

Website

http://www.altasemper.com/

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Alta Semper Capital is a London-based private equity firm founded in 2015 that invests US$20-60 million per transaction in healthcare, health-tech, and consumer companies across 12 African growth markets and MENA, through controlling stakes and active value creation.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Portfolio Management and Investment Advice (52394), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Private equity management
• Emerging markets investment
• Healthcare private equity
• Growth equity investing
• Consumer sector investing

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Fund Management: Alta Semper manages private equity funds on behalf of founding shareholders and various US and European institutional investors. Revenue is generated through management fees and carried interest from fund investments.
2. Private Equity Investment Returns: The firm generates returns through active value creation in portfolio companies, with investment strategy targeting 20-60 million USD per transaction in controlling stakes or active minority positions in healthcare and consumer companies across Africa and growth markets.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Alta Semper Capital is a private equity firm that manages investment funds deploying flexible capital into healthcare, health-tech, and consumer sectors across high-growth emerging economies (primarily Africa and the Middle East). The firm acquires controlling stakes or active minority positions in market-leading companies, typically deploying US$20-60 million per transaction through buy-and-build strategies supported by industry-leading operating partners. The firm is currently raising Growth Fund II (target size US$150 million) with anchor commitments from the EIB Group and IFC.

Product overview

Alta Semper Capital is a private equity firm (not a technology product company) that operates as a fund manager investing flexible capital in healthcare, health-tech, and consumer sectors across growth markets. The firm manages investment funds and holds portfolio companies including: MyDawa (e-pharmacy and telemedicine platform), Allmed (blood purification and dialysis medical devices), Nature's Rule (sports nutrition and dietary supplements), ODM (oncology and diagnostics services), and Macro Pharmaceuticals (cosmeceuticals). The primary offering is investment management services through its Growth Fund vehicles, not a unified software product or platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Alta Semper Growth Fund II Alta Semper's second growth fund targeting US$150 million total size, focused on scaling market-leading healthcare and consumer businesses across Africa and select growth markets. Emphasizes primary care, preventative medicine, diagnostics, medical devices, digital health, consumer wellness platforms, and disruptive technology. The fund deploys capital of US$20-60m per transaction into controlling stakes or active minority positions in healthcare and consumer companies across Africa.
• MyDawa Kenya's leading all-in-one digital health platform and the largest e-pharmacy in East Africa, enabling consumers to purchase authentic medicines, health and wellness products through partnerships with healthcare practitioners. Offers pharmaceutical, OTC, personal care products, online consultations, laboratory services, and telemedicine, with AI features for enhanced customer experience.
• Allmed World-class provider and innovator of blood purification solutions and artificial kidneys headquartered in the UK, with pioneering R&D centres in Germany. Leading enabler and supplier of life-saving dialysis treatments to the global south, operating a state-of-the-art manufacturing facility in Egypt exporting to 40+ countries. Developed the proprietary NIDUS infant haemodialysis system providing renal therapy for infants weighing 800g to 8kg using a single lumen catheter.
• Nature's Rule Leading sports nutrition and dietary supplements company headquartered in the UAE with manufacturing in Egypt. Operates the largest fully dedicated sports nutrition manufacturing facility in MENA, producing over 550 products. Portfolio includes proprietary brands Redrex (in collaboration with Big Ramy), Victor (with Victor Martinez), and Challenger, plus private-label clients. Exports to 15+ countries.
• ODM (Oncologie Diagnostic du Maroc) Morocco's largest oncology, radiology and diagnostics platform founded in 2014. Operates five facilities offering radiotherapy, chemotherapy, brachytherapy, and imaging/diagnostics services. Provides advanced oncology care across Morocco with expansion into Senegal, Ivory Coast, and Tunisia.
• Macro Pharmaceuticals Egypt's largest cosmeceutical (medicalized cosmetics) company established in 2002, marketing products to doctors across seven therapeutic areas. Specializes in production and sale of advanced cosmeceutical and nutraceutical products, regulated similar to cosmetics but distributed through medical representatives. Exports to nine markets across MENA and Africa from its Badr City, Cairo facility.

Quantifiable outcome

• 40+ countries positively impacted
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• Nature's Rule (Prowell Holding)flagshipStrategic or Co-development Partner · 19 January 2026Alta Semper acquired majority stake in Nature's Rule, a UAE-headquartered sports nutrition and dietary supplements company with manufacturing in Egypt. The partnership aims to expand product portfolio into broader health and wellness categories, enter new markets, and develop affordable fortified products for underserved communities. Founders retain significant stake and continue leading the business.
• Allmed GroupflagshipStrategic or Co-development Partner · 13 June 2024Alta Semper acquired Allmed Group, a UK-based producer of blood purification and dialysis solutions. The acquisition aims to expand Allmed's technology, production capacity, and market presence, particularly in Africa and Latin America, to improve healthcare access for patients with chronic kidney disease.
• MYDAWAcoreStrategic or Co-development Partner · 1 January 2021Alta Semper invested in MYDAWA, Kenya's leading e-pharmacy and digital health platform. The platform enables consumers to purchase authentic medicines and wellness products through partnerships with healthcare practitioners. MYDAWA is the largest e-pharmacy in East Africa.

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Ethos Private Equity: South Africa-headquartered private equity firm with consumer and healthcare investments across Sub-Saharan Africa. Comparable in growth-stage mandate and African sector specialization.
• Actis: Global emerging-markets private equity firm with deep Africa exposure across consumer, healthcare, and financial services. Comparable in theme-driven investing and DFI-backed fund structures serving growth markets.
• Development Partners International (DPI): Pan-African private equity firm focused on growth-stage consumer and healthcare businesses across Sub-Saharan Africa. Closest direct peer to Alta Semper in geography, sector focus, and growth-equity/buy-and-build approach.
• AfricInvest: Tunis-headquartered Africa-focused private equity and venture capital firm investing across consumer, healthcare, and financial services. Highly comparable on North/West Africa healthcare and consumer coverage.
• Verod Capital: West Africa-focused private equity firm investing growth capital in consumer and healthcare businesses in Nigeria and Ghana. Comparable as a regional growth-equity sponsor with overlapping target markets.
• Helios Investment Partners: Africa-focused private equity firm with consumer and healthcare investments across Sub-Saharan Africa. Directly comparable on regional focus, growth-stage mandate, and control-buyout strategy.
• Capitalworks: Pan-African private equity firm focused on mid-market control and growth investments across Sub-Saharan Africa. Comparable in sector-focused, buy-and-build investment approach.

Regional players

• SPE Capital: Tunisia-based private equity firm (formerly Swicorp) focused on North and Sub-Saharan Africa consumer and healthcare investments. Comparable on regional MENA-Africa focus and growth-equity strategy.

Emerging players

• British International Investment (BII): UK development finance institution that has backed Alta Semper's portfolio and provides direct healthcare/consumer investments across Africa. Comparable as a DFI co-investor with overlapping healthcare focus.

Broad incumbents

• TPG (Emerging Markets): Global alternative asset manager with significant emerging-markets and Africa exposure. Comparable as a broader incumbent active in growth-markets healthcare and consumer investing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/alta-semper-capital-llp

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alta Semper Capital